147 related articles for article (PubMed ID: 30280921)
21. Relative contribution of HIV infection, demographics and body mass index to bone mineral density.
Cotter AG; Sabin CA; Simelane S; Macken A; Kavanagh E; Brady JJ; McCarthy G; Compston J; Mallon PW;
AIDS; 2014 Sep; 28(14):2051-60. PubMed ID: 25265073
[TBL] [Abstract][Full Text] [Related]
22. Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss.
Sharma A; Cohen HW; Freeman R; Santoro N; Schoenbaum EE
Maturitas; 2011 Nov; 70(3):295-301. PubMed ID: 21944566
[TBL] [Abstract][Full Text] [Related]
23. Preoperative bone health assessment and optimization in spine surgery.
Anderson PA; Kadri A; Hare KJ; Binkley N
Neurosurg Focus; 2020 Aug; 49(2):E2. PubMed ID: 32738805
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.
Carr A; Grund B; Neuhaus J; Schwartz A; Bernardino JI; White D; Badel-Faesen S; Avihingsanon A; Ensrud K; Hoy J;
HIV Med; 2015 Apr; 16 Suppl 1(0 1):137-46. PubMed ID: 25711332
[TBL] [Abstract][Full Text] [Related]
25. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
[TBL] [Abstract][Full Text] [Related]
26. Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study.
Wiepjes CM; Vlot MC; Klaver M; Nota NM; de Blok CJ; de Jongh RT; Lips P; Heijboer AC; Fisher AD; Schreiner T; T'Sjoen G; den Heijer M
J Bone Miner Res; 2017 Jun; 32(6):1252-1260. PubMed ID: 28370342
[TBL] [Abstract][Full Text] [Related]
27. Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects.
Li Vecchi V; Soresi M; Giannitrapani L; Mazzola G; La Sala S; Tramuto F; Caruso G; Colomba C; Mansueto P; Madonia S; Montalto G; Di Carlo P
BMC Infect Dis; 2012 Aug; 12():192. PubMed ID: 22894751
[TBL] [Abstract][Full Text] [Related]
28. Increased risk factors associated with lower BMD in antiretroviral-therapy-naïve HIV-infected adult male.
Atencio P; Cabello A; Conesa-Buendía FM; Pérez-Tanoira R; Prieto-Pérez L; Carrillo I; Álvarez B; Arboiro-Pinel R; Díaz-Curiel M; Herrero-Beaumont G; Mediero A; Górgolas M
BMC Infect Dis; 2021 Jun; 21(1):542. PubMed ID: 34107907
[TBL] [Abstract][Full Text] [Related]
29. Bone Mineral Density Declines Twice as Quickly Among HIV-Infected Women Compared With Men.
Erlandson KM; Lake JE; Sim M; Falutz J; Prado CM; Domingues da Silva AR; Brown TT; Guaraldi G
J Acquir Immune Defic Syndr; 2018 Mar; 77(3):288-294. PubMed ID: 29140875
[TBL] [Abstract][Full Text] [Related]
30. Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.
Egerdie RB; Saad F; Smith MR; Tammela TL; Heracek J; Sieber P; Ke C; Leder B; Dansey R; Goessl C
Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):308-12. PubMed ID: 22641239
[TBL] [Abstract][Full Text] [Related]
31. Reduced bone mineral density in human immunodeficiency virus-infected individuals: a meta-analysis of its prevalence and risk factors.
Goh SSL; Lai PSM; Tan ATB; Ponnampalavanar S
Osteoporos Int; 2018 Mar; 29(3):595-613. PubMed ID: 29159533
[TBL] [Abstract][Full Text] [Related]
32. Controlled HIV viral replication, not liver disease severity associated with low bone mineral density in HIV/HCV co-infection.
El-Maouche D; Mehta SH; Sutcliffe C; Higgins Y; Torbenson MS; Moore RD; Thomas DL; Sulkowski MS; Brown TT
J Hepatol; 2011 Oct; 55(4):770-6. PubMed ID: 21338640
[TBL] [Abstract][Full Text] [Related]
33. Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection.
Vlot MC; Grijsen ML; Prins JM; de Jongh RT; de Jonge R; den Heijer M; Heijboer AC
PLoS One; 2018; 13(3):e0193679. PubMed ID: 29522570
[TBL] [Abstract][Full Text] [Related]
34. Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA.
Lo JC; Kim S; Chandra M; Ettinger B
Osteoporos Int; 2016 Dec; 27(12):3477-3484. PubMed ID: 27468900
[TBL] [Abstract][Full Text] [Related]
35. Trabecular bone scores in young HIV-infected men: a matched case-control study.
Kim YJ; Kang KY; Shin J; Jun Y; Kim SI; Kim YR
BMC Musculoskelet Disord; 2020 Feb; 21(1):94. PubMed ID: 32041580
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the fracture risk assessment tool for determining bone disease and the impact of secondary causes of osteoporosis in people living with HIV.
Vizcarra P; Gallego J; Vivancos MJ; Sifuentes WA; Llop M; Casado JL
HIV Res Clin Pract; 2020; 21(2-3):63-71. PubMed ID: 32698706
[TBL] [Abstract][Full Text] [Related]
37. Association of bone mineral density with hemoglobin and change in hemoglobin among older men and women: The Cardiovascular Health Study.
Valderrábano RJ; Buzkova P; Chang PY; Zakai NA; Fink HA; Robbins JA; Lee JS; Wu JY;
Bone; 2019 Mar; 120():321-326. PubMed ID: 30448304
[TBL] [Abstract][Full Text] [Related]
38. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection.
Arnsten JH; Freeman R; Howard AA; Floris-Moore M; Lo Y; Klein RS
AIDS; 2007 Mar; 21(5):617-23. PubMed ID: 17314524
[TBL] [Abstract][Full Text] [Related]
39. Effects of physical activity on bone mineral density in older adults: Korea National Health and Nutrition Examination Survey, 2008-2011.
Kim YA; Lee Y; Lee JH; Seo JH
Arch Osteoporos; 2019 Oct; 14(1):103. PubMed ID: 31655946
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral Therapy.
Bolland MJ; Horne AM; Briggs SE; Thomas MG; Reid IR; Gamble GD; Grey A
Calcif Tissue Int; 2019 Oct; 105(4):423-429. PubMed ID: 31250043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
